Cholinergic regulation of phase II interdigestive pancreatic secretion in humans

P. Layer, A. T H Chan, V. L W Go, A. R. Zinsmeister, E. P. DiMagno

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Small fluctuations in cholinergic input may be involved in the regulation of human interdigestive pancreatic secretion. To determine the effects of small changes in cholinergic tone on phase II interdigestive trypsin secretion, we gave cholinergic agonists or antagonists to 17 healthy fasting subjects who underwent gastrointestinal intubation. Duodenal trypsin outputs, gastroduodenal motility, and plasma levels of pancreatic polypeptide (PP) as a marker of cholinergic tone were measured during intravenous infusion of bethanechol (0, 5, or 40 μg · kg -1 · h -1) or atropine (0, 4, or 16 μg · kg -1 · h -1) given during phase II alone or in combination based on a 3 x 3 factorial design. Data were evaluated by a response surface analysis of the average log values for the test period (using the average of log values of the control period as a covariate). Bethanechol increased trypsin output (p < 0.05) and plasma concentrations of PP (p < 0.05) within the ranges of spontaneous fluctuations of trypsin output and PP during phase II, but did not disrupt the periodicity of pancreatic secretion or the characteristic cyclical pattern of interdigestive motility and induction of phase III activity. Atropine markedly decreased trypsin output (p < 0.05) and plasma concentrations of PP (p < 0.05) and abolished the cycling of interdigestive pancreatic secretion and motor activity. These data suggest the hypothesis that cholinergic pathways participate in the control of interdigestive pancreatic secretion during phase II, while enzyme secretion during phase III may be regulated by other mechanisms.

Original languageEnglish (US)
Pages (from-to)181-188
Number of pages8
JournalPancreas
Volume8
Issue number2
StatePublished - 1993

Fingerprint

Pancreatic Polypeptide
Trypsin
Cholinergic Agents
Bethanechol
Atropine
Gastrointestinal Intubation
Cholinergic Agonists
Cholinergic Antagonists
Periodicity
Intravenous Infusions
Fasting
Healthy Volunteers
Motor Activity
Enzymes

Keywords

  • Atropine
  • Bethanechol
  • Cholinergic control
  • Exocrine pancreatic secretion
  • Gastrointestinal motility
  • Interdigestive period
  • Motilin
  • Pancreatic polypeptide

ASJC Scopus subject areas

  • Endocrinology

Cite this

Layer, P., Chan, A. T. H., Go, V. L. W., Zinsmeister, A. R., & DiMagno, E. P. (1993). Cholinergic regulation of phase II interdigestive pancreatic secretion in humans. Pancreas, 8(2), 181-188.

Cholinergic regulation of phase II interdigestive pancreatic secretion in humans. / Layer, P.; Chan, A. T H; Go, V. L W; Zinsmeister, A. R.; DiMagno, E. P.

In: Pancreas, Vol. 8, No. 2, 1993, p. 181-188.

Research output: Contribution to journalArticle

Layer, P, Chan, ATH, Go, VLW, Zinsmeister, AR & DiMagno, EP 1993, 'Cholinergic regulation of phase II interdigestive pancreatic secretion in humans', Pancreas, vol. 8, no. 2, pp. 181-188.
Layer P, Chan ATH, Go VLW, Zinsmeister AR, DiMagno EP. Cholinergic regulation of phase II interdigestive pancreatic secretion in humans. Pancreas. 1993;8(2):181-188.
Layer, P. ; Chan, A. T H ; Go, V. L W ; Zinsmeister, A. R. ; DiMagno, E. P. / Cholinergic regulation of phase II interdigestive pancreatic secretion in humans. In: Pancreas. 1993 ; Vol. 8, No. 2. pp. 181-188.
@article{2033f903418044e3ae18016d471e11ec,
title = "Cholinergic regulation of phase II interdigestive pancreatic secretion in humans",
abstract = "Small fluctuations in cholinergic input may be involved in the regulation of human interdigestive pancreatic secretion. To determine the effects of small changes in cholinergic tone on phase II interdigestive trypsin secretion, we gave cholinergic agonists or antagonists to 17 healthy fasting subjects who underwent gastrointestinal intubation. Duodenal trypsin outputs, gastroduodenal motility, and plasma levels of pancreatic polypeptide (PP) as a marker of cholinergic tone were measured during intravenous infusion of bethanechol (0, 5, or 40 μg · kg -1 · h -1) or atropine (0, 4, or 16 μg · kg -1 · h -1) given during phase II alone or in combination based on a 3 x 3 factorial design. Data were evaluated by a response surface analysis of the average log values for the test period (using the average of log values of the control period as a covariate). Bethanechol increased trypsin output (p < 0.05) and plasma concentrations of PP (p < 0.05) within the ranges of spontaneous fluctuations of trypsin output and PP during phase II, but did not disrupt the periodicity of pancreatic secretion or the characteristic cyclical pattern of interdigestive motility and induction of phase III activity. Atropine markedly decreased trypsin output (p < 0.05) and plasma concentrations of PP (p < 0.05) and abolished the cycling of interdigestive pancreatic secretion and motor activity. These data suggest the hypothesis that cholinergic pathways participate in the control of interdigestive pancreatic secretion during phase II, while enzyme secretion during phase III may be regulated by other mechanisms.",
keywords = "Atropine, Bethanechol, Cholinergic control, Exocrine pancreatic secretion, Gastrointestinal motility, Interdigestive period, Motilin, Pancreatic polypeptide",
author = "P. Layer and Chan, {A. T H} and Go, {V. L W} and Zinsmeister, {A. R.} and DiMagno, {E. P.}",
year = "1993",
language = "English (US)",
volume = "8",
pages = "181--188",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Cholinergic regulation of phase II interdigestive pancreatic secretion in humans

AU - Layer, P.

AU - Chan, A. T H

AU - Go, V. L W

AU - Zinsmeister, A. R.

AU - DiMagno, E. P.

PY - 1993

Y1 - 1993

N2 - Small fluctuations in cholinergic input may be involved in the regulation of human interdigestive pancreatic secretion. To determine the effects of small changes in cholinergic tone on phase II interdigestive trypsin secretion, we gave cholinergic agonists or antagonists to 17 healthy fasting subjects who underwent gastrointestinal intubation. Duodenal trypsin outputs, gastroduodenal motility, and plasma levels of pancreatic polypeptide (PP) as a marker of cholinergic tone were measured during intravenous infusion of bethanechol (0, 5, or 40 μg · kg -1 · h -1) or atropine (0, 4, or 16 μg · kg -1 · h -1) given during phase II alone or in combination based on a 3 x 3 factorial design. Data were evaluated by a response surface analysis of the average log values for the test period (using the average of log values of the control period as a covariate). Bethanechol increased trypsin output (p < 0.05) and plasma concentrations of PP (p < 0.05) within the ranges of spontaneous fluctuations of trypsin output and PP during phase II, but did not disrupt the periodicity of pancreatic secretion or the characteristic cyclical pattern of interdigestive motility and induction of phase III activity. Atropine markedly decreased trypsin output (p < 0.05) and plasma concentrations of PP (p < 0.05) and abolished the cycling of interdigestive pancreatic secretion and motor activity. These data suggest the hypothesis that cholinergic pathways participate in the control of interdigestive pancreatic secretion during phase II, while enzyme secretion during phase III may be regulated by other mechanisms.

AB - Small fluctuations in cholinergic input may be involved in the regulation of human interdigestive pancreatic secretion. To determine the effects of small changes in cholinergic tone on phase II interdigestive trypsin secretion, we gave cholinergic agonists or antagonists to 17 healthy fasting subjects who underwent gastrointestinal intubation. Duodenal trypsin outputs, gastroduodenal motility, and plasma levels of pancreatic polypeptide (PP) as a marker of cholinergic tone were measured during intravenous infusion of bethanechol (0, 5, or 40 μg · kg -1 · h -1) or atropine (0, 4, or 16 μg · kg -1 · h -1) given during phase II alone or in combination based on a 3 x 3 factorial design. Data were evaluated by a response surface analysis of the average log values for the test period (using the average of log values of the control period as a covariate). Bethanechol increased trypsin output (p < 0.05) and plasma concentrations of PP (p < 0.05) within the ranges of spontaneous fluctuations of trypsin output and PP during phase II, but did not disrupt the periodicity of pancreatic secretion or the characteristic cyclical pattern of interdigestive motility and induction of phase III activity. Atropine markedly decreased trypsin output (p < 0.05) and plasma concentrations of PP (p < 0.05) and abolished the cycling of interdigestive pancreatic secretion and motor activity. These data suggest the hypothesis that cholinergic pathways participate in the control of interdigestive pancreatic secretion during phase II, while enzyme secretion during phase III may be regulated by other mechanisms.

KW - Atropine

KW - Bethanechol

KW - Cholinergic control

KW - Exocrine pancreatic secretion

KW - Gastrointestinal motility

KW - Interdigestive period

KW - Motilin

KW - Pancreatic polypeptide

UR - http://www.scopus.com/inward/record.url?scp=0027403828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027403828&partnerID=8YFLogxK

M3 - Article

C2 - 8096337

AN - SCOPUS:0027403828

VL - 8

SP - 181

EP - 188

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 2

ER -